Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gestational surrogacy.

Peter R Brinsden1

  • 1Bourn Hall Clinic, Bourn, Cambridge CB3 7TR, UK. brinsdenp@aol.com

Human Reproduction Update
|December 3, 2003
PubMed
Summary
This summary is machine-generated.

Gestational surrogacy, using in vitro fertilization (IVF), enables women without a uterus to have genetically related children. This treatment option shows good success rates and limited complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vitro fertilization: four decades of reflections and promises.

Biochimica et biophysica acta·2011
Same author

Thirty years of IVF: the legacy of Patrick Steptoe and Robert Edwards.

Human fertility (Cambridge, England)·2009
Same author

Optimal follicle and oocyte numbers for cryopreservation of all embryos in IVF cycles at risk of OHSS.

Reproductive biomedicine online·2008
Same author

Recombinant human leukemia inhibitory factor does not improve implantation and pregnancy outcomes after assisted reproductive techniques in women with recurrent unexplained implantation failure.

Fertility and sterility·2008
Same author

A founding member of the British Fertility Society and pioneer in ultrasound, laparoscopy and amniocentesis.

Human fertility (Cambridge, England)·2005
Same author

'The presence of blood in the transfer catheter negatively influences outcome at embryo transfer'.

Human reproduction (Oxford, England)·2005
Same journal

Clinical outcomes and euploidy rates of embryos derived from zygotes with nonpronuclear (0PN) and monopronuclear (1PN) in IVF or ICSI cycles: a systematic review and meta-analysis.

Human reproduction update·2026
Same journal

Sperm mitochondrial DNA copy number: a marker of male fertility and reproductive success.

Human reproduction update·2026
Same journal

Embryo-derived extracellular vesicles and their potential as biomarkers for embryo quality during IVF: a systematic review.

Human reproduction update·2026
Same journal

Endometriosis and ovarian cancer: epidemiological evidence, molecular insights, and clinical decision-making.

Human reproduction update·2026
Same journal

Maternal genetic variants associated with aneuploid conception: a narrative review.

Human reproduction update·2026
Same journal

Iron overload disorders in adults: a comprehensive review of gonadal function, reproductive, and sexual health.

Human reproduction update·2026
See all related articles

Area of Science:

  • Reproductive Medicine
  • Assisted Reproductive Technology

Background:

  • Gestational surrogacy offers a solution for women with medical conditions preventing pregnancy, such as an absent uterus.
  • In vitro fertilization (IVF) is integral to creating embryos for gestational surrogacy.

Purpose of the Study:

  • To evaluate the efficacy and safety of gestational surrogacy using IVF.
  • To assess pregnancy rates and ethical considerations in gestational surrogacy.

Main Methods:

  • Embryo creation via IVF using commissioning couple's gametes.
  • Embryo transfer to a screened, fertile surrogate host.
  • Routine IVF procedures adapted for gestational surrogacy.

Main Results:

  • Clinical pregnancy rates up to 40% per embryo transfer.
Keywords:
Genetics and Reproduction

Related Experiment Videos

  • Live birth rates of 60% reported in some series.
  • Gestational surrogacy has been largely complication-free with reassuring follow-up data.

    • Conclusions:

    • Gestational surrogacy is a successful treatment for women unable to carry their own genetic children.
    • Ethical and legal issues are minimized compared to other surrogacy types.
    • This assisted reproductive technology provides a viable option for a specific patient group.